Other research groups have also endeavored to elucidate the underlying mechanism by which TMEM43 leads to fibrosis in ARVC through modulation of TGFβ (13, 14). The gene discussed is TMEM43; the disease is arrhythmogenic right ventricular cardiomyopathy.